Signature Wealth Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$658K Hold
715
0.25% 86
2025
Q4
$768K Hold
715
0.31% 71
2025
Q3
$546K Hold
715
0.21% 81
2025
Q2
$557K Hold
715
0.22% 83
2025
Q1
$591K Hold
715
0.23% 84
2024
Q4
$552K Hold
715
0.22% 82
2024
Q3
$633K Sell
715
-93
-12% -$83.6K 0.25% 79
2024
Q2
$732K Hold
808
0.32% 76
2024
Q1
$587K Sell
808
-154
-16% -$110K 0.27% 81
2023
Q4
$561K Buy
+962
New +$562K 0.26% 80
2023
Q2
$552K Buy
1,178
+386
+49% +$162K 0.26% 79
2023
Q1
$272K Buy
792
+76
+11% +$25.6K 0.13% 87
2022
Q4
$262K Sell
716
-31
-4% -$11K 0.13% 86
2022
Q3
$242K Sell
747
-21
-3% -$6.65K 0.12% 87
2022
Q2
$249K Sell
768
-90
-10% -$27K 0.12% 82
2022
Q1
$246K Buy
+858
New +$221K 0.11% 81
2018
Q4
Sell
-275
Closed -$30K 194
2018
Q3
$30K Hold
275
0.02% 130
2018
Q2
$23K Hold
275
0.02% 139
2018
Q1
$21K Sell
275
-16
-5% -$1.29K 0.02% 141
2017
Q4
$25K Buy
+291
New +$24.8K 0.02% 132

Other funds holding LLY

Signature Wealth Management Group's LLY Position: Q1 2026 in Review

Signature Wealth Management Group held its Eli Lilly (LLY) position steady in Q1 2026 at 715 shares worth $658K. The position accounts for 0.25% of the portfolio, ranked #86.

Signature Wealth Management Group first reported a position in LLY in Q4 2017 and has held it in 20 quarters since. The position peaked at $768K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Signature Wealth Management Group held 715 shares of Eli Lilly worth $658K as of Q1 2026.
  • Signature Wealth Management Group left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.25% of Signature Wealth Management Group's portfolio in Q1 2026, its #86 holding.
  • Signature Wealth Management Group first reported a position in Eli Lilly in Q4 2017 and has held it in 20 quarters since.
  • Signature Wealth Management Group's Eli Lilly position peaked at $768K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Signature Wealth Management Group's 13F filing for Q1 2026, filed 1 Apr 2026.